Search results for: 'drug paas'

The SynBio field has evolved well over the past two decades, with significant technology disruptions leading to new opportunities and remarkable growth potential. Advances in SynBio technologies have transformed drug discovery and therapeutics development, accelerating the identification of novel drug targets and high-throughput compound screening ...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

The cloud services market in Latin America has been witnessing changes in the consumer mindset toward cloud computing. Companies of different sizes and across a variety of verticals are increasingly understanding the benefits of the SaaS and PaaS solutions and therefore are making investments in the cloud. The SaaS market has diversified industry...

This study analyzes the global Infrastructure-as-a-Service (IaaS) and Platform-as-a-Service (PaaS) market from 2025 to 2031, covering hyperscale cloud providers, AI-focused neoclouds, and regional and sovereign cloud operators across North America, Latin America, EMEA, and Asia-Pacific. It provides market size and growth forecasts, examines regiona...

In this analysis, Stratecast provides an overview of the PaaS landscape. We look at the various manifestations of Platform as a Servicepublic and private, open and proprietary, domain-specific and general. We examine the value of PaaS to developers, and what shapes their choices across PaaS providers, including pricing, functionality, and deployme...

Today’s global workforce is younger, more connected, and more dispersed than it has been at any point in the past, which means it demands advanced solutions. Enterprises have discovered that cloud technologies are foundational to power this workplace transformation and drive agile business. Lessons from the COVID-19 pandemic will continue to ac...

Cloud infrastructure and platforms are the foundational elements that underpins enterprise digital transformation. The uncertain economic climate of 2022, which has carried over into 2023, has undoubtedly affected enterprise IT budgets and priorities. Macroeconomic trends—high interest rates, inflation, stagnant consumer demand, a weak housing ma...

The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...

The conventional drug discovery and diagnostics technologies are unable to cope up with the current disease management practices. To this end, researchers have explored possibilities beyond life sciences. Specifically, they have figured out that the use of engineering principles to biological systems can revolutionize the drug discovery and diagnos...